| CLBCX | ETNMX | CLBCX / ETNMX | |
| Total Expense Ratio | 1.35 | 1.02 | 132% |
| Annual Report Gross Expense Ratio | 1.35 | 1.02 | 132% |
| Fund Existence | 24 years | 10 years | - |
| Gain YTD | 10.112 | 3.006 | 336% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 1000 | 25% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 269B | 381M | 70,604% |
| Annual Yield % from dividends | 1.02 | 1.88 | 54% |
| Returns for 1 year | 8.50 | 2.22 | 383% |
| Returns for 3 years | 35.19 | 26.11 | 135% |
| Returns for 5 years | 31.70 | 17.69 | 179% |
| Returns for 10 years | 71.78 | 78.59 | 91% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FFMMX | 60.02 | 0.01 | +0.02% |
| American Funds American Mutual 529-F-2 | |||
| PHEFX | 13.12 | N/A | N/A |
| T. Rowe Price Hedged Equity | |||
| HBGHX | 15.65 | N/A | N/A |
| Hartford Healthcare HLS IB | |||
| GSMAX | 18.62 | -0.04 | -0.21% |
| Goldman Sachs Small/Mid Cap Growth A | |||
| HIGUX | 19.28 | -3.57 | -15.62% |
| Carillon Eagle Growth & Income R6 | |||